DrugPatentWatch Database Preview

Details for Patent: 6,667,314

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 6,667,314 protect, and when does it expire?

Patent 6,667,314 protects SELZENTRY and is included in two NDAs.

This patent has ninety-six patent family members in fifty-five countries.

Summary for Patent: 6,667,314

Title:	Tropane derivatives useful in therapy
Abstract:	The present invention provides compounds of the formula: ##STR1## wherein R.sup.1 is C.sub.3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C.sub.1-6 alkyl optionally substituted by one or more fluorine atoms, or C.sub.3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R.sup.2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
Inventor(s):	Perros; Manoussos (County of Kent, GB), Price; David Anthony (County of Kent, GB), Stammen; Blanda Luzia Christa (County of Kent, GB), Wood; Anthony (County of Kent, GB)
Assignee:	Pfizer, Inc. (New York, NY)
Application Number:	09/865,950
Patent Claim Types: see list of patent claims	Compound; Composition; Use; Process;

Drugs Protected by US Patent 6,667,314

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Viiv Hlthcare	SELZENTRY	maraviroc	SOLUTION;ORAL	208984-001	Nov 4, 2016		RX	Yes	Yes			Y	Y		METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1
Viiv Hlthcare	SELZENTRY	maraviroc	TABLET;ORAL	022128-003	Nov 4, 2016		RX	Yes	No			Y	Y		METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1
Viiv Hlthcare	SELZENTRY	maraviroc	TABLET;ORAL	022128-004	Nov 4, 2016		RX	Yes	No			Y	Y		METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1
Viiv Hlthcare	SELZENTRY	maraviroc	TABLET;ORAL	022128-001	Aug 6, 2007		RX	Yes	No			Y	Y		METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1
Viiv Hlthcare	SELZENTRY	maraviroc	TABLET;ORAL	022128-002	Aug 6, 2007		RX	Yes	Yes			Y	Y		METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1

Foreign Priority and PCT Information for Patent: 6,667,314

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0015835	Jun 27, 2000

International Family Members for US Patent 6,667,314

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	1965
Argentina	028622
Argentina	060159
Austria	260914
Austria	407134
Australia	2001252482
Australia	5248201